Cifarelli, Vincenza <br/><br/>
Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms.  [electronic resource] 

 -  Diabetes  May 2015 
 - 1632-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1939-327X 
<br/><br/><label>Standard No.: </label>10.2337/db14-1132  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Body Weight<br/>Cell Cycle--drug effects<br/>Diet, Diabetic<br/>Energy Intake<br/>Glucose Intolerance<br/>Hypoglycemic Agents--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Metformin--therapeutic use<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Obese<br/>MicroRNAs--genetics<br/>Neoplasms, Experimental--drug therapy<br/>Pancreatic Neoplasms--drug therapy<br/>Prediabetic State--drug therapy<br/>Random Allocation<br/>Sirolimus--therapeutic use<br/>Snail Family Transcription Factors<br/>Transcription Factors--genetics<br/>Vimentin--genetics